Therefore, we postulated that the PI3K-AKT pathway might be the key pathway mediating the sulforaphane mechanism of EMT suppression in endometrial cancer cells and investigated sulforaphane effects on AKT signaling. Here, AKT1 is linked to endometrial cancer.